New insights into the pathophysiology of the small airways in asthma

Annals of Thoracic Medicine

Volumn 2, Issue 1, 2007, Pages 28-33

  Hamid, Qutayba ^a   Tulic, Meri ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Allergic inflammation; Asthma; Distal airways; Parenchyma

Indexed keywords

EID: 33846671883     PISSN: 18171737     EISSN: None     Source Type: Journal    
DOI: 10.4103/1817-1737.30361     Document Type: Review

References (67)

1. Dunnill MS. The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol 1960;13:27-33.
2. Curschmann H. Ueber bronchiolitis exsudative und ihr Verhaltniss zum asthma nervosum. Dtsch Arch Klin Med 1882;32:1-34.
3. Levine G, Housley E, MacLeod P, Macklem PT. Gas exchange abnormalities in mild bronchitis and asymptomatic asthma. N Eng J Med 1970;282:1277-82.
4. Despas PJ, Leroux M, Macklem PT. Site of airway obstruction in asthma as determined by measuring maximal expiratory flow breathing air and a helium-oxygen mixture. J Clin Invest 1972;51:3235-43.
5. Yanai M, Sekizawa K, Ohrui T, Sasaki H, Takishima T. Site of airway obstruction in pulmonary disease: Direct measurement of intrabronchial pressure. J Appl Physiol 1992;72:1016-23.
6. Ohrui T, Sekizawa K, Yanai M, Morikawa M, Jin Y, Sasaki H, et al. Partitioning of pulmonary responses to inhaled methacholine in subjects with asymptomatic asthma. Am Rev Respir Dis 1992;146:1501-5.
7. Kuwano K, Bosken CH, Pare PD, Bai TR, Wiggs BR, Hogg JC. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993;148:1220-5.
8. Wagner EM, Bleecker ER, Permutt S, Liu MC. Direct assessment of small airways reactivity in human subjects. Am J Respir Crit Care Med 1998;157:447-52.
9. Djukanovic R, Wilson JW, Lai CK, Holgate ST, Howarth PH. The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage and endobronchial biopsy in asthma. Am Rev Respir Dis 1991;143:772-7.
10. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR. Increases in activated T lymphocytes, eosinophils and cytokine mRNA expression for IL (interleukin)-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Resp Cell Mol Biol 1993;8:35-42.
11. Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG, et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997;100:44-51.
12. Minshall EM, Hogg JC, Hamid QA. Cytokine mRNA expression in asthma is not restricted to the large airways. J Allergy Clin Immunol 1998;101:386-90.
13. Taha RA, Minshall EM, Miotto D, Shimbara A, Luster A, Hogg JC, et al. Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals. J Allergy Clin Immunol 1999;103:476-83.
14. Carroll N, Cooke C, James A. The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. Eur Respir J 1997;10:292-300.
15. Faul JL, Tormey VJ, Leonard C, Burke CM, Farmer J, Horne SJ, et al. Lung immunopathology in cases of sudden asthma death. Eur Respir J 1997;10:301-7.
16. Christodoulopoulos P, Leung DY, Elliott MW, Hogg JC, Muro S, Toda M, et al. Increased number of glucocorticoid receptorbeta-expressing cells in the airways in fatal asthma. J Allergy Clin Immunol 2000;106:479-84.
17. Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Resp Crit Care Med 1996;154:1505-10.
18. Kraft M, Martin RJ, Wilson S, Djukanovic R, Holgate ST. Lymphocyte and eosinophil influx into alveolar tissue in NA (Nocturnal asthma). Am J Respir Crit Care Med 1999;159:228-34.
19. Carroll N, Carello S, Cooke C, James A. Airway structure and inflammatory cells in fatal attacks of asthma. Eur Respir J 1996;9:709-15.
20. Synek M, Anto JM, Beasley R, Frew AJ, Holloway L, Lampe FC, et al. Immunopathology of fatal soybean dust-induced asthma. Eur Respir J 1996;9:54-7.
21. Weibel ER. Morphometry of the human lung. Academic Press: New York; 1963.
22. Woolcock AJ. Effects of drugs on small airways. Am J Respir Crit Care Med 1998;157:S203-7.
23. James AL, Pare PD, Hogg JC. The mechanics of airway narrowing in asthma. Am Rev Respir Dis 1989;139:242-6.
24. Huber HL, Koessler KK. The pathology of bronchial asthma. Arch Intern Med 1922;30:689-760.
25. Haley KJ, Sunday ME, Wiggs BR, Kozakewich HP, Reilly JJ, Mentzer SJ, et al. Inflammatory cell distribution within and along asthmatic airways. Am J Respir Crit Care Med 1998;158:565-72.
26. Hamid QA. Peripheral inflammation is more important than central inflammation. Respir Med 1997;91:11-2.
27. Saetta M, Di Stefano A, Rosina C, Thiene G, Fabbri LM. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991;143:138-43.
28. Kraft M. The distal airways: Are they important in asthma? Eur Respir J 1999;14:1403-17.
29. Kraft M, Vianna E, Martin RJ, Leung DY. Nocturnal asthma is associated with reduced glucocorticoid receptor binding affinity and decreased steroid responsiveness at night. J Allergy Clin Immunol 1999;103:66-71.
30. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose GC (Glucocorticoids). Am J Respir Crit Care Med 1997;156:737-43.
31. Kuyper LM, Pare PD, Hogg JC, Lambert RK, Ionescu D, Woods R, et al. Characterization of airway plugging in fatal asthma. Am J Med 2003;115:6-11.
32. Macklem PT, Mead J. Resistance of central and peripheral airways measured by a retrograde catheter. J Appl Physiol 1967;22:395-401.
33. Brown R, Woolcock AJ, Vincent NJ, Macklem PT. Physiological effects of experimental airway obstruction with beads. J Appl Physiol 1969;27:328-35.
34. Mead J, Takishima T, Leith D. Stress distribution in lungs: A model of pulmonary elasticity. J Appl Physiol 1970;28:596-608.
35. Sly PD, Willet KE, Kano S, Lanteri CJ, Wale J. Pirenzepine blunts the pulmonary parenchymal response to inhaled methacholine. Pulm Pharmacol 1995;8:123-9.
36. Ludwig MS, Romero PV, Bates JH. A comparison of the doseresponse behavior of canine airways and parenchyma. J Appl Physiol 1989;67:1220-5.
37. Hall GL, Petak F, McMenamin C, Sly PD. The route of antigen delivery determines the airway and lung tissue mechanical responses in allergic rats. Clin Exp Allergy 1999;29:562-8.
38. Peták F, Hantos Z, Adamicza Á, Asztalos T, Sly PD. Methacholineinduced bronchoconstriction in rats: Effects of intravenous vs. aerosol delivery. J Appl Physiol 1997;82:1479-87.
39. Suki B, Petak F, Adamicza A, Hantos Z, Lutchen KR. Partitioning of airway and lung tissue properties: Comparison of in situ and open-chest conditions. J Appl Physiol 1995;79:861-9.
40. Sato J, Suki B, Davey BL, Bates JH. Effect of methacholine on low-frequency mechanics of canine airways and lung tissue. J Appl Physiol 1993;75:55-62.
41. Romero PV, Robatto FM, Simard S, Ludwig MS. Lung tissue behavior during methacholine challenge in rabbits in vivo. J Appl Physiol 1992;73:207-12.
42. Tepper R, Sato J, Suki B, Martin JG, Bates JH. Low-frequency pulmonary impedance in rabbits and its response to inhaled methacholine. J Appl Physiol 1992;73:290-5.
43. Ingenito EP, Davision B, Fredberg JJ. Tissue resistance in the guinea pig at baseline and during methacholine constriction. J Appl Physiol 1993;75:2541-8.
44. Salerno FG, Moretto A, Dallaire M, Ludwig MS. How mode of stimulus affects the relative contribution of elastance and hysteresivity to changes in lung tissue resistance. J Appl Physiol 1995;78:282-7.
45. Tulic MK, Wale JL, Petak F, Sly PD. Muscarinic blockade of methacholine induced airway and parenchymal lung responses in anaesthetized rats. Thorax 1999;54:531-7.
46. Preuss JM, Hall GL, Sly PD. Repeat measurement of respiratory mechanics using the forced oscillation technique in non-paralyzed rats. Pulm Pharmacol Ther 1999;12:173-83.
47. Petak F, Hall GL, Sly PD. Repeated measurements of airway and parenchymal mechanics in rats by using low-frequency oscillations. J Appl Physiol 1998;84:1680-6.
48. Hall GL, Hantos Z, Wildhaber JH, Petak F, Sly PD. Methacholine responsiveness in infants assessed with low frequency forced oscillation and forced expiration techniques. Thorax 2001;56:42-7.
49. Hall GL, Hantos Z, Petak F, Wildhaber JH, Tiller K, Burton PR, et al. Airway and respiratory tissue mechanics in normal infants. Am J Respir Crit Care Med 2000;162:1397-402.
50. Hayden MJ, Petak F, Hantos Z, Hall G, Sly PD. Using low-frequency oscillation to detect bronchodilator responsiveness in infants. Am J Respir Crit Care Med 1998;157:574-9.
51. Sly PD, Hayden MJ, Petak F, Hantos Z. Measurements of low-frequency respiratory impedance in infants. Am J Respir Crit Care Med 1996;154:161-6.
52. Van Brabandt H, Cauberghs M, Verbeken E, Moerman P, Lauweryns JM, Van de Woestijne KP. Partitioning of pulmonary impedance in excised human and canine lungs. J Appl Physiol 1983;55:1733-42.
53. Ingram RH Jr. Physiological assessment of inflammation in the peripheral lung of asthmatic patients. Lung 1990;168:237-47.
54. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968;278:1355-60.
55. Wagner EM, Liu MC, Weinmann GG, Permutt S, Bleecker ER. Peripheral lung resistance in normal and asthmatic subjects. Am Rev Respir Dis 1990;141:584-8.
56. Wiggs BR, Bosken C, Pare PD, James AL, Hogg JC. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;145:1251-8.
57. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992;145:669-74.
58. Booth H, Richmond I, Ward C, Gardiner PV, Harkawat R, Walters EH. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Am J Respir Crit Care Med 1995;152:45-52.
59. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis 1992;145:890-9.
60. Gauvreau GM, Inman MD, Kelly M, Watson RM, Dorman SC, O'Byrne PM. Increased levels of airway neutrophils reduce the inhibitory effects of inhaled glucocorticosteroids on allergeninduced airway eosinophils. Can Respir J 2002;9:26-32.
61. Esmailpour N, Hogger P, Rabe KF, Heitmann U, Nakashima M, Rohdewald P. Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo. Eur Respir J 1997;10:1496-9.
62. Dolovich MB, Rhem R, Gerrard L, Coates G. Lung deposition of coarse CFC vs fine HFA (hydrofluoroalkane) pMDI (Metereddose inhalers) earosols of BDP (Beclomethasone dipropionate) in asthma. Am J Respir Crit Care Med 2000;161:A33.
63. Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metereddose inhaler compared with CFC-beclomethasone. Eur Respir J 1998;12:1346-53.
64. Busse WW, Brazinsky S, Jacobson K, Stricker W, Schmitt K, Vanden Burgt J, et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol 1999;104:1215-22.
65. Vanden Burgt JA, Busse WW, Martin RJ, Szefler SJ, Donnell D. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma. J Allergy Clin Immunol 2000;106:1209-26.
66. Goldin JG, Tashkin DP, Kleerup EC, Greaser LE, Haywood UM, Sayre JW, et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: Assessment with functional helical thin-section computed tomography. J Allergy Clin Immunol 1999;104:S258-67.
67. Hauber HP, Gotfried M, Newman K, Danda R, Servi RJ, Christodoulopoulos P, et al. Effect of HFA-flunisolide on peripheral lung inflammation in asthma. J Allergy Clin Immunol 2003;112:58-63.